e-learning
resources
2021
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Statin use is associated with reduced mortality after respiratory viral infection
Juan Antonio Franco-Peláez, Laura Esteban-Lucia, María de los Ángeles Zambrano Chacón, Ana María Pello-Lázaro, Ana María Venegas Rodriguez, Luis Nieto Roca, Camila Sofia García-Talavera, Andrea Kallmeyer Mayor, Felipe Villar Alvarez, Ricardo Fernandez Roblas, Oscar Gonzalez-Lorenzo, José Tuñón, Borja Ibañez, Alvaro Aceña
Source:
ERJ Open Res, 7 (1) 00365-2020; 10.1183/23120541.00365-2020
Journal Issue:
January
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Juan Antonio Franco-Peláez, Laura Esteban-Lucia, María de los Ángeles Zambrano Chacón, Ana María Pello-Lázaro, Ana María Venegas Rodriguez, Luis Nieto Roca, Camila Sofia García-Talavera, Andrea Kallmeyer Mayor, Felipe Villar Alvarez, Ricardo Fernandez Roblas, Oscar Gonzalez-Lorenzo, José Tuñón, Borja Ibañez, Alvaro Aceña. Statin use is associated with reduced mortality after respiratory viral infection. ERJ Open Res, 7 (1) 00365-2020; 10.1183/23120541.00365-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Enhanced severity of virus associated asthma exacerbations is not associated with delayed viral clearance and increased viral load
Source: Eur Respir J 2005; 26: Suppl. 49, 280s
Year: 2005
Immunosuppression is associated with lower morbidity and mortality in the 2017/2018 influenza epidemic
Source: International Congress 2019 – Clinical challenges in respiratory infection
Year: 2019
Fenofibrate is associated with higher risk of mortality in patients with tuberculosis infection
Source: International Congress 2019 – Tuberculosis: from diagnosis to complications
Year: 2019
Factors associated and attack rate in adenovirus infection among children with chronic respiratory disease
Source: Annual Congress 2011 - Paediatric epidemiology: bronchiolitis, pneumonia, asthma and spirometry in non-respiratory conditions
Year: 2011
Impact of viral load on mortality in hospitalized patients affected by Covid-19 infection.
Source: Virtual Congress 2021 – COVID – 19: treatments and predictive factors
Year: 2021
Inflammatory responses predict long-term mortality risk in community-acquired pneumonia
Source: Eur Respir J 2011; 37: 1439-1446
Year: 2011
COPD as an additional risk factor for cardiovascular and respiratory events in patients with respiratory viral infection
Source: International Congress 2019 – Cardiovascular comorbidities in COPD
Year: 2019
The risk of mycobacterial infections associated with inhaled corticosteroid use
Source: Eur Respir J, 50 (3) 1700037; 10.1183/13993003.00037-2017
Year: 2017
Relation between respiratory diseases and the development of cardiovascular events in patients with respiratory viral infection
Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections
Year: 2020
COPD and respiratory viral infections as risk factors for the development of cardiovascular events
Source: Virtual Congress 2020 – Prognosis and integrated management of COPD
Year: 2020
Respiratory syncitial virus infection in hospitalized Brazilian infants with acute lower respiratory disease: incidence and associated factors
Source: Eur Respir J 2005; 26: Suppl. 49, 628s
Year: 2005
Potential causes of increased long-term mortality after pneumonia
Source: Eur Respir J 2011; 37: 1306-1307
Year: 2011
Is COPD pharmacotherapy associated with increased incidence of community-acquired pneumonia?
Source: Annual Congress 2008 - Community-acquired pneumonia and COPD: what do we know?
Year: 2008
Are there risk factors that may influence use of antibiotics in viral lower respiratory tract infections in children?
Source: Annual Congress 2008 - Paediatric airway diseases - pathophysiology and monitoring
Year: 2008
Predictors of in-hospital mortality in influenza infection.
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019
Impact of bacterial co-infection with COVID-19 on morbidity and mortality
Source: Virtual Congress 2021 – COVID - 19 epidemiology
Year: 2021
Early initiation of antiretroviral therapy results in decreased morbidity and mortality among patients with advanced HIV disease
Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis
Year: 2008
Macrolide therapy is associated with lower 30-day mortality in patients with non-pneumonia and pneumonia severe sepsis
Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections
Year: 2011
Bacteremic pneumococcal pneumonia is associated with an increased rate of cardiovascular events
Source: International Congress 2019 – Pneumonia in 2019: antimicrobial resistance, cardiovascular complications and diagnosis
Year: 2019
Risk factors for bacterial infection in exacerbated COPD requiring admission
Source: Eur Respir J 2001; 18: Suppl. 33, 153s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept